News

Science is an amazing career that involves life-long learning and discovery that never gets old.

Nikoleta Tsvetanova, PhD, assistant professor of pharmacology and cancer biology, has been awarded the 2025 Division for Molecular Pharmacology Early Career Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET).

Donald McDonnell, PhD, Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology, has been awarded the Endocrine Society’s J

G. Greg Wang is among five faculty in the School of Medicine who have been promoted or appointed to the rank of full professor.

 

Ko was awarded the fellowship for his research studying how low levels of androgens facilitate activation of a specific protein, resulting in increased tumor growth. He hopes to develop drugs that exploit this protein signaling process to inhibit prostate cancer cell growth.

Zou is one of several fellows from Duke who will participate in a year of joint institutional activities designed to build awareness and effectiveness in the context of academic leadership. The provosts of the Atlantic Coast Conference member institutions created the Academic Leaders Network Program to develop the leadership potential of participating faculty.

Tavros Therapeutics, co-founded by Kris Wood, PhD, associate professor of pharmacology and cancer biology, and Eoin McDonnell, PhD, a graduate of the Duke University Molecular Cancer Biology PhD Program , has been acquired by Vividion Therapeutics, a subsidiary of global life sciences company Bayer AG.

Binita Chakraborty, PhD, a postdoctoral fellow in the Department of Pharmacology and Cancer Biology, won the Robert and Barbara Bell Basic Science Cancer Research Award for the most innovative basi

Zhao Zhang, PhD, has been promoted to associate professor with tenure, effective January 1, 2025.